ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 37

Cardiovascular Disease in Immune-Mediated Inflammatory Diseases: Cross Sectional Analysis of the Influence of Demographic and Traditional Cardiovascular Risk Factors

Luis Rodriguez-Rodriguez1,2, Pedro P Perrotti3, Adrìa Aterido3, Jesús Tornero4, Carlos Ferrandiz5, Juan D. Cañete6, Antonio Fernandez-Nebro7, Javier P Gisbert8, Eugeni Domènech9,10, María López-Lasanta3, Sara Marsal3, Benjamín Fernández-Gutiérrez1,11 and IMID Consortium, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Department of Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 3Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 4Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain, 5Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 6Rheumatology, Hospital Clinic and IDIBAPS, Barcelona, Spain, 7Rheumatology, Hospital Regional Carlos Haya, Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain, 8Gastroenterology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 9Gastroenterology & Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 10CIBERehd, Madrid, Spain, 11Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, inflammatory bowel disease (IBD), Psoriatic arthritis, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose : Our aim was 1) to analyze the association between demographic and traditional cardiovascular risk factors (CVRF) and cardiovascular disease (CVD) in subjects affected with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis (Ps), psoriatic arthritis (PsA), Crohn’s disease (CD), or ulcerative colitis (UC), and 2) to compare the standardized prevalence of CVD among these conditions.

Methods : Subjects included in this cross-sectional study were collected as part of the Immune-Mediated Inflammatory Disease Consortium between 2007-2010. Demographic and clinical data was collected using standardized questionnaires during a clinical interview with close questions and review of medical records. Multivariate logistic regression models adjusted by demographic (gender, age, educational level, elapsed time from IMID diagnosis) and traditional CVRF [dyslidepemia (DL), type 2 diabetes (T2D), obesity (OB), ever smoking] were constructed for each IMID. Results for each variable were combined using inverse variance weighted metaanalysis. Standardized prevalence for each IMID, adjusted by demographic and traditional CVRF [per 100 patients, with 95% confidence intervals (CI)] was calculated using marginal analysis.

Results: 9951 patients were included (Table 1). Table 2 shows the association between demographic and traditional CVRF and CVD in each IMID. When results from the 6 cohorts were combined, males, lower educational level, older age and more time elapsed from disease diagnosis, and presence of DL and T2D were independently associated with a higher risk of CVD. SLE exhibited the highest standardized prevalence, followed by RA, Ps, CD, PsA and UC (Figure 1).

Conclusion : The contribution to CV risk of demographic and traditional CVRF is different for each IMID. SLE showed the higher standardize prevalence of CVD when compared to other IMIDs.

 

 

Table 1: Demographic characteristics and prevalence of CVD disease and traditional CV risk factors of the patients included in this study.

 

RA (n = 2152)

PsA (n = 1147)

Ps (n = 2497)

SLE (n = 760)

CD (n = 1938)

UC (n = 1457)

Age, (n)  X (IQR)

(1996) 61

(52 to 70)

(1113) 52

(41.09 to 63)

(2430) 47

(36 to 59)

(702) 44

(35 to 55)

(1913) 39

(32 to 49)

(1436) 47

(37 to 58.12)

Women, n (%)

1.567 (77.69)

522 (47.28)

1.057 (43.46)

671 (93.19)

956 (49.84)

663 (46.01)

 Calendar year at IMID

diagnosis, (n)  X (IQR)

(2144) 1998

(1991 to 2004)

(1137) 2003

(1996 to 2007)

(2482) 1992

(1980 to 2001)

(678) 1999

(1993 to 2004)

(1314) 1998

(1993 to 2002)

(975) 1998

(1993 to 2002)

Elapsed time from IMID diagnosis

to study§, in years , (n)  X (IQR)

(2132) 10

(5 to 17)

(1076) 7

(3 to 13)

(2480) 17

(8 to 29)

(675) 10

(6 to 17)

(1313) 10

(6 to 15)

(975) 10

(7 to 16)

Secondary or higher education, n (%)

655 (33.73)

449 (44.46)

1278 (54.20)

378 (54.00)

1187 (62.77)

785 (55.48)

CVD, n (%)

91 (4.23)

24 (2.09)

94 (3.76)

24 (3.16)

14 (0.72)

22 (1.51)

Current/past smoker, n (%)

828 (49.49)

533 (59.55)

1.411 (69.68)

369 (62.02)

1.282 (74.62)

727 (62.08)

Arterial hypertension, n (%)

638 (29.65)

–

476 (19.06)

178 (23.42)

123 (6.35)

148 (10.16)

Dyslipidemia, n (%)

433 (20.12)

157 (13.69)

436 (17.46)

125 (16.45)

68 (3.51)

127 (8.72)

Type 2 diabetes, n (%)

172 (7.99)

92 (8.02)

203 (8.13)

24 (3.16)

28 (1.44)

55 (3.77)

Obesity, n (%)

366 (19.02)

250 (24.56)

612 (25.82)

102 (15.36)

184 (9.97)

198 (14.25)

Number of DMARDs, X [IQR]

2 (1-3)

1 (0-2)

0 (0-0)

2 (1-2)

1 (0-1)

0 (0-1)

Patients with biological drugs, n (%)

914 (42.47)

299 (26.07)

493 (19.74)

47 (6.18)

282 (14.55)

70 (4.80)

 

Table 2: Multivariate logistic regression models to analyze the influence of demographic and traditional cardiovascular (CV) risk factors in the prevalence of CV disease in each of our 6 cohorts.

Figure 1: Standardized prevalence of cardiovascular disease, with 95% confidence intervals, for each IMID.

 

 


Disclosure: L. Rodriguez-Rodriguez, None; P. P. Perrotti, None; A. Aterido, None; J. Tornero, None; C. Ferrandiz, None; J. D. Cañete, None; A. Fernandez-Nebro, None; J. P. Gisbert, None; E. Domènech, None; M. López-Lasanta, None; S. Marsal, None; B. Fernández-Gutiérrez, None.

To cite this abstract in AMA style:

Rodriguez-Rodriguez L, Perrotti PP, Aterido A, Tornero J, Ferrandiz C, Cañete JD, Fernandez-Nebro A, Gisbert JP, Domènech E, López-Lasanta M, Marsal S, Fernández-Gutiérrez B. Cardiovascular Disease in Immune-Mediated Inflammatory Diseases: Cross Sectional Analysis of the Influence of Demographic and Traditional Cardiovascular Risk Factors [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-disease-in-immune-mediated-inflammatory-diseases-cross-sectional-analysis-of-the-influence-of-demographic-and-traditional-cardiovascular-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-disease-in-immune-mediated-inflammatory-diseases-cross-sectional-analysis-of-the-influence-of-demographic-and-traditional-cardiovascular-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology